• No results found

QMS for Software as a Medical Device [SaMD] Lessons Learned from a Quality Perspective

N/A
N/A
Protected

Academic year: 2021

Share "QMS for Software as a Medical Device [SaMD] Lessons Learned from a Quality Perspective"

Copied!
29
0
0

Loading.... (view fulltext now)

Full text

(1)

MedCon 2015

Francis Blacha, Robert Banta

© 2015 Eli Lilly and Company

QMS for Software as a Medical Device [SaMD]

Lessons Learned from a Quality Perspective

(2)

Evolution from Physical to Digital Devices

2 © 2015 Eli Lilly and Company

App running on mobile device

From

To

Mechanical injection pens:

--Instructions for Use (IFU) (printed)

--Labeling (printed)

--Patient Inserts (PI) (printed)

--Secondary Packaging (required)

--Cartons (required)

Software as a Medical Device (SaMD):

--Instructions for Use (IFU) (on screen)

--Labeling (on screen)

--Patient Inserts (PI) (none)

--Secondary Packaging (none)

--Cartons (none)

(3)

QS Elements Commonalities & Differences

Physical vs Digital Devices

3 © 2015 Eli Lilly and Company

Elements Common? Different?

Data Integrity

Training

Product Launch Approvals

CAPA

Cybersecurity

Risk Management

Human Factors

Purchasing Controls/Supplier Management

Digital Connectivity

Complaints

Recall/Market Withdrawal

Change Control/Configuration Management

(4)

4 © 2015 Eli Lilly and Company

Challenge:

Evaluate & enhance Device QMS to enable Development

& Commercialization of SaMDs

QS Elements Commonalities & Differences

Physical vs Digital Devices

App running on mobile device

(5)

Assessing QMS: Support

Development & Commercialization of SaMD

5 © 2015 Eli Lilly and Company

Typical linear development life cycle model for physical devices

(6)

6 © 2015 Eli Lilly and Company

Source IBM: http://www.ibm.com/developerworks/rational/library/compliant-agile-medical-device/fig05_lg.html

Typical nonlinear (iterative) development life cycle model for SaMD

Assessing QMS: Support

(7)

1. Integrating Standards:

Provide clear expectations on how to achieve quality objectives. The standards describe what and who is responsible.

2. Business Processes:

Simple and effective, provide information on how operations are to be performed to meet requirements per the integrated standards.

3. Organizational:

Defined roles to assure clear responsibilities and accountabilities. Skills must meet the needs of the specific roles.

4. Governance/Management Oversight:

Ensures management is involved when decisions are required at the appropriate accountable levels.

“System of Quality” Model

7 © 2015 Eli Lilly and Company

(8)

8 © 2015 Eli Lilly and Company

Applying the Lilly “System of Quality” results in consistent outputs:

 High-quality products  Accurate and

complete safety and efficacy data through

design, execution,

monitoring and continuous improvement of Quality

These outputs are achieved via:  Applying sound scientific principles  Balancing product commercialization effort commensurate with risk  Facilitating continuous improvement

(9)

Lessons Learned So Far…

Some Recent Experiences

© 2015 Eli Lilly and Company 9

(10)

© 2015 Eli Lilly and Company 10

U.S. Medical Device Classification Decision Process

Integrated Standards

Integrated Standards – Device Classification

Determine Intended Use Determine Product Codes(s) & Regulation Number(s)

Decision Process

Outcomes

510(k) Submission & “GMP’s” required No submission, but GMP’s are required Device ?

Mobile App (NOT mobile medical apps) Yes

No No submission, GMP

“exempt”, except for specific provisions

Class II

Class I

PMA Submission & “GMP’s” required

Class III

(11)

Integrated Standards

© 2015 Eli Lilly and Company

EU Device “Standalone Software” Decision Process

1

Integrated Standards – Device Classification

Determine Intended Purpose Device ? Stand Alone S/W NOT a medical device No

•the software does not perform an

action on data, or it performs an action limited to storage, archival,

Communication, ‘simple search’

1MEDDEV 2.1/6 January 2012 Active medical

device

Yes influence Drive or another device ? Classification Rules 9 - 12 Classified the same as the other device Yes No

Decision Process

Outcomes & Requirements

Class IIb Class IIa Class I (It depends) Annex VII: •Tech Documentation •Declaration of Conformity

•AE reporting &

complaint handling

•Recalls

Annex II:

•Quality System •Notified Body Cert •Tech Documentation •Declaration of

Conformity

•AE reporting &

complaint handling

•Recalls

11 11

(12)

© 2015 Eli Lilly and Company 12

International Medical Device Regulators Forum

(IMDRF)

Integrated Standards

Source: http://www.imdrf.org/docs/imdrf/final/meetings/imdrf-meet-140829-washington-presentation-samd.pdf

(13)

© 2015 Eli Lilly and Company 13

IMDRF Framework for Risk Categorization of SaMDs

Integrated Standards

Integrated Standards – Device Classification

(14)

© 2015 Eli Lilly and Company 14

Mapping Standards Applicable to SaMDs

Integrated Standards

Source: http://www.emdt.co.uk/article/developing-medical-device-software-iso-62304

(15)

Integrated Standards –Standards Analysis

© 2015 Eli Lilly and Company 15

Assessed traditional Device Standards associated with software, including:

• Software Validation

• Medical Device Software

• Device QSR

• Device QSM

Evaluation of Various Standards

Integrated Standards

(16)

© 2015 Eli Lilly and Company 16

Mapping Standards Applicable to SaMDs

Integrated Standards –Standards Analysis

Integrated Standards

(17)

Standards Analysis Exercise Output was a Roadmap addressing

IEC 62304 Risk-scaled Deliverables across Design Control Phases

© 2015 Eli Lilly and Company 17

SaMD Medical Device Software Lifecycle Model (IEC 62304: 2006)

Integrated Standards

(18)

© 2015 Eli Lilly and Company 18

Developed a Global Quality Standard that defines

SaMD quality requirements for (among others):

 Design controls

 Risk management (including cybersecurity)

 Human Factors

 Distribution

 Purchasing Controls

 Labeling

 Privacy

 Data Integrity

 Product Recall

Integrated Standards – Analysis Output

Integrated Standards

(19)

19 © 2015 Eli Lilly and Company

SaMD Formative Human Factors Studies

• Formative HF Study to verify the effectiveness of knowledge gained

• Essential to have a cross-functional HF team

Rapid iteration of HF Studies allows for easier change/verify cycles in software

versus conventional change/verify cycles for physical devices.

Users interact

with software

Usability experts

take user feedback

Programmers make design

changes based on feedback

Users/Programmers

verify changes

Business

Processes – Human Factors

Business Processes

(20)

Business

Processes – Product Recall

20 © 2015 Eli Lilly and Company

SaMD Recall/Market Withdrawal

Commonalities/Differences

Problem Identification

Risk Assessment & Decision to recall

Recall plan & communication planning Issue recall communications Recall / Market Withdrawal Monitor/review recall Effectiveness/ Update stakeholders Recall Complete Plan for physical removal

from market

Accomplished via print media and traditional mailings

Physical removal from market

Physical counting of recalled product

Plan for SaMD deactivation or forced

software upgrade

Accomplished via e-mail notifications

Digital deactivation or forced software upgrade

Measured digitally via SaMD connection with

cloud

Business Processes

(21)

21 © 2015 Eli Lilly and Company

Business

Processes – Patient Instructions

Labels and Instructions for Use (IFU)

Physical Device

SaMD

Label attached to device Label integrated into software and displayed on screen

IFU included with packaging IFU integrated into software and displayed on screen

Label update via printing of new labels Label updated electronically via software upgrade

IFU update via printing of new IFU IFU updated electronically via software upgrade

Label and IFU subject to loss, alteration, or replacement without authorization

Software label and IFU cannot be lost, altered, or replaced

Business Processes

(22)

22 © 2015 Eli Lilly and Company

Source: http://www.pmoplanet.com

Organization

: Roles and Responsibilities

SaMD require new technical expertise:

 Mobile Application Software Engineer

 IT Network Infrastructure Specialist

 Global Information Security Architect

SaMD require identification of right span of control plus

clear accountability:

 Device classification

 Software safety classification determination

 Risk management process ownership

 Patient safety decision ownership

 Cloud service provider supplier chain ownership

(23)

23 © 2015 Eli Lilly and Company

Source: http://blog.procore.com/

Organization: Defining Roles and Responsibilities

SaMDs require clear lines of accountability for

among other items issue escalation/resolution

regarding:

 SaMD commercialization decisions

 SaMD launch approvals

 Privacy decisions

 Data analytics usages

 Cybersecurity practices (app level and Cloud level)

 Due diligence of Cloud vendors

(24)

24 © 2015 Eli Lilly and Company

Organization - Capability

Physical Device Team:

 Project Manager

 Regulatory Affairs/Qualified Person  Medical Device Development Engineer

 Medical Device Quality Assurance Representative  Human Factors Consultant

 Medical Affairs Consultant

Additional Software skills:

 Mobile Application Software Developer  Global Information Security Architect  IT Quality Assurance Representative  Cloud Infrastructure Consultant

Example of Team Participants

(25)

Gov./Mgmt. Oversight

25 © 2015 Eli Lilly and Company

Focusing on

governance/

management

oversight:

 Management

involvement

 Problem

escalation

 Decision

making

 Auditing

Source: http://www.praxity.com/about-us/Pages/The-Governance-of-the-Alliance.aspx

(26)

26 © 2015 Eli Lilly and Company

Governance/Management Oversight

Gov./Mgmt. Oversight

(27)

© 2015 Eli Lilly and Company 27

So far…

 Early identification of the regulatory classification for SaMD both US and OUS

 Establish global quality standard (quality requirements)

 Ensure involvement of IT team in oversight of Cloud infrastructure

 Modify recall/market withdrawal processes to address SaMD technology

capability

 Formative HF Studies enhanced by modifying SaMD code from daily patient

interactions

 Enhance product surveillance processes and patient safety processes to address

the unique technology associated with SaMD

(28)

Conclusion

Integrated Standards Business Processes Organization Governance/ Management Oversight

 Established Cloud change control governance

 Developed cross-functional due diligence process for selection of Cloud vendors

 Addressed auditing

responsibilities for MMA/SaMDs

 Increased HF Study design enhancements  Modified recall/

market withdrawal

 Adapted process controls for e-labels/e-IFUs

 Brought mobile app

software SMEs into device design team

 Added Cloud

infrastructure vendor & established supplier

controls for Cloud vendor  Created a Quality

standard that addresses design control and product commercialization requirements for MMA/SaMDs

© 2015 Eli Lilly and Company 28

“System of Quality’ Model used to enhance device QMS to support development and

commercialization of SaMD

(29)

Questions?

References

Related documents

Several validation studies are currently ongoing which assess alternative methods for the safety and potency testing of human and veterinary vaccines, e.g., a serolog- ical assay

The optimal rate-delay trade-offs for scalar quantization were formulated as the minimum cost solution of a dynamic program and it is established that asymptotically (in the number

In response, the company adopted Informatica Test Data Management to streamline acquisition of realistic and purposeful data to avoid copying entire data sets from production

This work suggests that Latin America’s record of economic instability, as measured by real output growth and changes in the real exchange rate, can be explained by instability in

The CP proposed that firms would only be able to promote UCIS to retail clients meeting the criteria to be certified sophisticated investors, self-certified sophisticated investors

The proposed adaptive control scheme, applied together with DG droop controls and secondary cooperative voltage and frequency controller to real time, calculated the voltage

Corporate Groups are required to provide at least 3 examples of significant opportunities for improving the energy efficiency of the group that have been identified in

1 Cause Analog monitors only – The Matrox display driver may be trying to use settings your monitor doesn’t support.. This can happen if the display resolution was changed to one